Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Conformis

Explore full profile

Customized Partial & Total Knee Replacements

Billerica, United StatesFounded 2004Biotech & Life Sciences
Valuation $18M Market cap · 2023
Revenue $76M Latest reported FY
Total funding $100–500M Disclosed equity funding

About Conformis

Conformis, Inc. operates as a medical technology company, positioning itself at the intersection of advanced imaging and additive manufacturing to address the orthopedic joint replacement market. Founded in 2004 by Dr. Philipp Lang, a radiologist and professor with an M.D. and MBA, the company was born from his dissatisfaction with the limitations of standard, off-the-shelf implants. Lang's background in musculoskeletal radiology at institutions like Harvard Medical School and his experience in the medical device industry directly informed the company's core concept of making the implant fit the patient, not the other way around.

Read full description

The company's business model centers on its proprietary iFit Image-to-Implant technology platform, which utilizes CT scans to create a 3D digital model of a patient's unique anatomy. This data-driven approach allows for the design and manufacture of individually sized and shaped joint replacement implants for knees and hips, along with patient-specific surgical instrumentation. This process aims to provide a more precise anatomical fit, preserve healthy bone, and simplify the surgical procedure for orthopedic surgeons. Revenue is generated through the sale of these personalized implant systems directly to hospitals and other healthcare facilities. The company serves a global market, with a sales presence in the United States, Europe, and Asia.

Conformis' product line includes a range of knee and hip replacement systems designed to treat conditions like osteoarthritis. Key offerings have included the iTotal CR (cruciate-retaining) and iTotal PS (posterior-stabilized) for total knee replacements, as well as partial knee solutions like the iUni and iDuo. The company also developed the Conformis Hip System. A significant milestone was the company's initial public offering (IPO) on July 7, 2015, trading on the NASDAQ under the symbol CFMS. Over its history, Conformis has secured numerous FDA 510(k) clearances for its products, starting with its iTotal system in 2011 and its hip system in 2017. Despite its technological advancements and having sold over 149,000 implants, the company faced financial struggles. In September 2023, Conformis was acquired by restor3d, a private medical device company specializing in 3D-printed orthopedic solutions. The acquisition combined restor3d's expertise with Conformis's established product lines and intellectual property, with the goal of creating a comprehensive personalized orthopedic device company. Keywords: patient-specific implants, custom joint replacement, orthopedic medical device, 3D printed implants, knee arthroplasty, hip arthroplasty, personalized surgery, medical imaging technology, iFit technology, surgical instrumentation, osteoarthritis treatment, additive manufacturing, medical device manufacturing, orthopedic surgery solutions, patient-conforming implants, knee replacement systems, hip replacement systems, restor3d, Philipp Lang, custom medical devices

Source: Dealroom company data

At a glance

Founded
2004
Headquarters
Billerica, United States
Listing
IPO 2015
Sector
Biotech & Life Sciences
Power Law
Colt$25–100M revenue

Investors

10 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A1 investor entered at this stage

  • Thorner Ventures

Series B and later9 investors entered at this stage

  • Industrial Bank of Taiwan
  • Merrill Lynch
  • Oxford Finance
  • CDIB BioScience Ventures
  • Calibrium
  • Axel Johnson
  • AGC EQUITY PARTNERS LIMITED
  • East West Bank
  • Innovatus Capital Partners
Team profiled 17 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 1 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
5 countries with
team presence
🇺🇸 United States55.9%
🇮🇳 India42.1%
🇭🇰 Hong Kong0.7%
🇩🇪 Germany0.7%
🇫🇷 France0.7%
5 countries shown
Web traffic by country
4.4K monthly visits
across markets
🇺🇸 United States100%
Top 1 markets shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Conformis on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Conformis on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.